Clinical Trial Update: Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a proton pump inhibitor to prevent upper gastrointestinal injury in patients on dual antiplatelet therapy after coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Gastrointestinal Ulcer or Erosion

Drugs mentioned

• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastrointestinal Ulcer (Peptic) or Erosion, Anti-Platelet Therapy | Phase 4 | Status: UNKNOWN